Assembly Bill A5289

2021-2022 Legislative Session

Authorizes a pharmacist to substitute a brand name prescription drug for the generic equivalent of such drug if requested to do so by the patient

download bill text pdf

Sponsored By

Archive: Last Bill Status - Stricken


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

2021-A5289 (ACTIVE) - Details

Law Section:
Education Law
Laws Affected:
Amd §6810, Ed L
Versions Introduced in Other Legislative Sessions:
2009-2010: A4045
2011-2012: A2732
2013-2014: A2621
2015-2016: A2382
2017-2018: A1840
2019-2020: A1924

2021-A5289 (ACTIVE) - Summary

Authorizes a pharmacist to substitute a brand name prescription drug for the generic equivalent of such drug if requested to do so by the patient and record the request.

2021-A5289 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   5289
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 12, 2021
                                ___________
 
 Introduced by M. of A. ANGELINO -- read once and referred to the Commit-
   tee on Consumer Affairs and Protection
 
 AN  ACT  to  amend  the  education  law,  in relation to authorizing the
   substitution of brand name prescription drugs by a pharmacist
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section  1.  Paragraph  (a)  of  subdivision  6 of section 6810 of the
 education law, as amended by chapter 590 of the laws of 2011, is amended
 to read as follows:
   (a) Every prescription written in this state by a person authorized to
 issue such prescription shall be on prescription  forms  containing  one
 line  for  the  prescriber's signature. The prescriber's signature shall
 validate the prescription. Every electronic prescription  shall  provide
 for  the  prescriber's  electronic  signature,  which shall validate the
 electronic prescription. Imprinted conspicuously on  every  prescription
 written  in  this state in eight point upper case type immediately below
 the signature line shall be the words: "THIS PRESCRIPTION WILL BE FILLED
 GENERICALLY UNLESS PRESCRIBER WRITES 'd a w' IN THE BOX  BELOW".  Unless
 the  prescriber  writes  d a w in such box in the prescriber's own hand-
 writing or, in the case of electronic prescriptions,  inserts  an  elec-
 tronic  direction  to  dispense  the  drug  as written, the prescriber's
 signature or electronic signature shall designate  approval  of  substi-
 tution  by  a  pharmacist of a drug product pursuant to paragraph (o) of
 subdivision one of section two hundred six of the public health law.  No
 other letters or marks in  such  box  shall  prohibit  substitution.  No
 prescription forms used or intended to be used by a person authorized to
 issue a prescription shall have 'd a w' preprinted in such box. Such box
 shall  be  placed  directly under the signature line and shall be three-
 quarters inch in length and one-half inch in height,  or  in  comparable
 form for an electronic prescription as may be specified by regulation of
 the  commissioner.  Immediately below such box shall be imprinted in six
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.